Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex McKesson CEO named Quidel chairman

Executive Summary

Former Sandoz Pharma and McKesson CEO Mark Pulido has been named chairman of Quidel, the diagnostics firm announced June 2. Pulido, 51, has been a director of Quidel for two years and was most recently chairman and CEO of BenefitPoint, Inc. Pulido resigned as head of McKesson in 1999 following the disclosure of reporting irregularities associated with the wholesaler's merger with the health information firm HBOC (1"The Pink Sheet" June 28, 1999, p. 6)...
Advertisement

Related Content

McKesson Splits CEO Into Operations & Strategy: Hammergren & Mahoney
McKesson Splits CEO Into Operations & Strategy: Hammergren & Mahoney
Advertisement
UsernamePublicRestriction

Register

PS044108

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel